Dr. Toussaint has been a TBSI member since 2007.
Raised in North Carolina, Dr. Toussaint attended UNC Chapel Hill for his undergraduate and medical school education.
There, he was recognized as a Morehead Scholar, Phi Beta Kappa and Alpha Omega Alpha inductee, and Howard Holderness Distinguished Medical Scholar, graduating with Highest Honors.
From Chapel Hill, he moved to Minnesota to complete residency training in Rochester at The Mayo Clinic.
While there, he participated in the Mayo Clinician Investigator Training Program and completed a basic science fellowship in neuro-oncology.
He won the resident research award for the Department of Neurology and was national runner-up for the American Academy of Neurological Surgeons research award.
He completed his chief residency in neurological surgery in 2007 and moved to Bryan/College Station where he now resides with his wife and their five children.

Dr. Toussaint has a research interest in the molecular biology of high grade glioma, an aggressive type of primary brain tumor.
His work focuses in three related areas - the microRNA control of invasion, the biology of the interface between blood vessel and tumor, and the delivery of novel therapies.
He has an active role in teaching and research at the Texas A&M Health Science Center College of Medicine.

"This research and this line of research in general is very exciting," added Dr. L. Gerard Toussaint III, an assistant professor of neuroscience and experimental therapeutics at Texas A&M Health Science Center College of Medicine and a neurosurgeon with the Texas Brain and Spine Institute in Bryan.
"Their approach is to genetically engineer a virus that would only be turned on in the stem cell population."

This type of virus-against-cancer therapy may be the next generation of anti-cancer treatments, he said.